4-aminopyridine has been researched along with aminacrine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alderson, B; Dettbarn, C; Otero, AS; Palade, P; Volpe, P | 1 |
Gillespie, JI; Wood, PG | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
3 other study(ies) available for 4-aminopyridine and aminacrine
Article | Year |
---|---|
Direct inhibition of inositol-1,4,5-trisphosphate-induced Ca2+ release from brain microsomes by K+ channel blockers.
Topics: 4-Aminopyridine; Aminacrine; Animals; Barium; Brain; Calcium; Dogs; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Microsomes; Potassium Channels; Quinine; Tetraethylammonium Compounds | 1989 |
In permeabilised endothelial cells IP3-induced Ca2+ release is dependent on the cytoplasmic concentration of monovalent cations.
Topics: 4-Aminopyridine; Amifampridine; Aminacrine; Animals; Aorta; Calcium; Cations; Cattle; Cells, Cultured; Cobalt; Cytoplasm; Endothelium, Vascular; Inositol 1,4,5-Trisphosphate; Meglumine; Membrane Potentials; Potassium; Potassium Channel Blockers; Tetraethylammonium | 1998 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |